A delegation from the Science and Technology Innovation Department of Shenzhen Qianhai Administration Bureau visited Shenzhen Cell Valley Research and investigation
On November 7th, Lin Ted, the first administrative director of Science and Technology Innovation Department of Qianhai Administration Bureau, Men Jiaqi, the second administrative director Wang Huanyu, the first administrative director of Free Trade Affairs Department, and Lu Wei, deputy Director of Regional Planning Institute of Qianhai Innovation Research Institute visited Shenzhen Cell Valley for investigation and investigation. Professor Shi Yuanyuan, chairman of our company, Sun Rui, director of Marketing Department, and Wang Lu, director of general Office warmly received and held the symposium.
Under the guidance of wang lu director, the leadership of the visiting team visited the wisdom of Shenzhen cell valley hall, the cell valley in the field of cell and gene therapy strategic planning, founding team, the core technology of retrovirus vector preparation, cell products unique advantages of production process, and the implementation of the whole process traceability strict control has a preliminary understanding.
Symposium, chairman of the history of professor said, Shenzhen cell valley has the core technical team, successfully using the independent production of industrial retrovirus vector, prepared for more than 50 target CAR T cell products, has been in the domestic medical institutions of clinical research show excellent safety and effectiveness. In addition, Shenzhen Cell Valley has set up a number of subsidiaries in Beijing and the Greater Bay Area. In view of the recent joint document on the special CGT policies provided by the Guangdong Free Trade Zone, Shi Yuan is very interested and is considering the establishment of a Cell Valley branch in the Qianhai Free Trade Zone, so as to make full use of the national policies to help the development of the cell therapy industry in Shenzhen.
Lin Ted, director of the introduction, before the sea in the center of a large bay area, is the important node, in nearly three years, before the construction of international medical service agglomeration area, from the first Hong Kong and Macao medical institutions support policy, start the first hospital quality international review certification, landing before the first Hong Kong-owned hospital, built before the opening of the first international club kang, to approved "Hong Kong and Macao medicine machinery" policy, the introduction of Shenzhen first Hong Kong nurse cross-border practice, a series of "first" innovation to promote Shenzhen international medical service breakthrough. At present, Qianhai has gathered 10 international medical institutions. In 2023, four hospitals above level III in Qianhai provided international medical services to more than 42,000 overseas patients (72% of Hong Kong patients), providing high-quality medical supporting services for overseas people to work and live in Qianhai. Not only that, before the sea administration also built the international influence, new quality productivity innovation entrepreneurship platform-sea port youth dream works (hereinafter referred to as the "dream works"), the dream works for Hong Kong youth innovation employment, mainland quality kechuang enterprises in the development of Hong Kong "first stop" "choice" "interpreta dream area". The purpose of this visit is to conduct a deeper communication with Shenzhen Cell Valley through field research, and hope to promote the further development of Shenzhen and Hong Kong in the field of cell therapy.
This visit has enhanced the understanding of both sides. Both sides look forward to broader cooperation in the future, bring more positive and significant health benefits to patients in Shenzhen and Hong Kong, and truly realize the corporate vision of "cells benefit all living beings and genes create the future".
Lin Ted, director of the introduction, before the sea in the center of a large bay area, is the important node, in nearly three years, before the construction of international medical service agglomeration area, from the first Hong Kong and Macao medical institutions support policy, start the first hospital quality international review certification, landing before the first Hong Kong-owned hospital, built before the opening of the first international club kang, to approved "Hong Kong and Macao medicine machinery" policy, the introduction of Shenzhen first Hong Kong nurse cross-border practice, a series of "first" innovation to promote Shenzhen international medical service breakthrough. At present, Qianhai has gathered 10 international medical institutions. In 2023, four hospitals above level III in Qianhai provided international medical services to more than 42,000 overseas patients (72% of Hong Kong patients), providing high-quality medical supporting services for overseas people to work and live in Qianhai. Not only that, before the sea administration also built the international influence, new quality productivity innovation entrepreneurship platform-sea port youth dream works (hereinafter referred to as the "dream works"), the dream works for Hong Kong youth innovation employment, mainland quality kechuang enterprises in the development of Hong Kong "first stop" "choice" "interpreta dream area". The purpose of this visit is to conduct a deeper communication with Shenzhen Cell Valley through field research, and hope to promote the further development of Shenzhen and Hong Kong in the field of cell therapy.
This visit has enhanced the understanding of both sides. Both sides look forward to broader cooperation in the future, bring more positive and significant health benefits to patients in Shenzhen and Hong Kong, and truly realize the corporate vision of "cells benefit all living beings and genes create the future".
